Found 68 with Last Name = 'giovani' and Initial = 's' 
Affinity DataIC50: 600nMAssay Description:Inhibition of Plasmodium falciparum serine protease subtilisin-like protease 1by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 600nMAssay Description:Inhibition of Plasmodium falciparum serine protease subtilisin-like protease 1by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.70E+3nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.90E+3nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of Plasmodium falciparum serine protease subtilisin-like protease 1by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.20E+3nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.40E+3nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: >7.00E+3nMAssay Description:Inhibition of BACE1 in HEK293 cells expressing APP NFEV and APP K612V mutant assessed as generation of EV40/EV42 by electrochemiluminescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.50E+3nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 9.20E+3nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of BACE1 in HEK293 cells expressing APP NFEV and APP K612V mutant assessed as generation of EV40/EV42 by electrochemiluminescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of BACE1 in human SH-SY5Y cells expressing APP NFEV and wild-type alpha cleavage site assessed as generation of EV40/EV42 by electrochemil...More data for this Ligand-Target Pair
Affinity DataIC50: 1.28E+4nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.43E+4nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.48E+4nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.49E+4nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 1.81E+4nMAssay Description:Inhibition of human recombinant BACE1 using [acetyl-C(W8044Eu)-EVNLDAEFK-QSY7] as substrate by TR-FRET assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of Plasmodium falciparum SUB1 by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of Plasmodium falciparum SUB1 by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 3.30E+4nMAssay Description:Inhibition of Plasmodium falciparum serine protease subtilisin-like protease 1by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of Plasmodium falciparum SUB1 by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 4.00E+4nMAssay Description:Inhibition of Plasmodium falciparum SUB1 by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of Plasmodium falciparum SUB1 by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of Plasmodium falciparum SUB1 by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of Plasmodium falciparum SUB1 by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+4nMAssay Description:Inhibition of Plasmodium falciparum serine protease subtilisin-like protease 1by fluorimetric assayMore data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of BACE1 in human SH-SY5Y cells expressing APP NFEV and wild-type alpha cleavage site assessed as generation of EV40/EV42 by electrochemil...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 120nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 4.10E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 350nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 1.06E+4nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 6.00E+4nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 5.70E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 820nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 2.80E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 3.70E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 150nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 7.10E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 2.10E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 230nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 270nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 480nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 200nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 1.14E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 1.40E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 480nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 96nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 440nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 160nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
TargetCystic fibrosis transmembrane conductance regulator(Homo sapiens (Human))
D3-Pharmachemistry
Curated by ChEMBL
D3-Pharmachemistry
Curated by ChEMBL
Affinity DataEC50: 1.90E+3nMAssay Description:Potentiation of human CFTR F508 deletion mutant expressed in rat FRT cells coexpressing HS-YFP assessed as increase in iodide influx pre-incubated fo...More data for this Ligand-Target Pair
